Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic dexmedetomidine for prevention of emergence agitation in children undergoing vascular interventional procedures
ChiCTR1900021325Phase 4Not yet recruiting
- Sponsor
- Kunming Children's Hospital
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by Kunming Children's Hospital. Primary endpoint: Incidence of emergence agitation in PACU. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR1900021325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021325.